Overview

Patient Monitoring Devices Market is poised to value at a CAGR of over 8.4% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Patient Monitoring Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Patient Monitoring Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Patient Monitoring Devices Market:
• GE HEALTHCARE
• MEDTRONIC PLC
• KONINKLIJKE PHILIPS N.V.
• ABBOTT LABORATORIES
• NIHON KOHDEN CORPORATION
• MASIMO CORPORATION
• OMRON CORPORATION
• EDWARDS LIFESCIENCES CORPORATION
• HILL-ROM HOLDINGS, INC.
• DRÄGERWERK AG & CO. KGAA
• NATUS MEDICAL
• GETINGE AB
• COMPUMEDICS LIMITED
• SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
• NONIN
• BIOTRONIK
• BOSTON SCIENTIFIC CORPORATION
(Note: The list of the major players will be updated with the latest market scenario and trends)

Patient Monitoring Devices Market Segmentation:
By Product
• Blood Glucose Monitoring Systems
 o Self-monitoring Blood Glucose Systems
 o Continuous Glucose Monitoring Systems
• Cardiac Monitoring Devices
 o ECG Devices
 o Implantable Loop Recorders
 o Event Monitors
 o Mobile Cardiac Telemetry Monitors
 o Smart/Wearable ECG Monitors
• Multi-parameter Monitoring Devices
 o Low-acuity Monitoring Devices
 o Mid-acuity Monitoring Devices
 o High-acuity Monitoring Devices
• Respiratory Monitoring Devices
 o Pulse Oximeters
 o Spirometers
 o Capnographs
 o Peak Flow Meters
• Temperature Monitoring Devices
 o Handheld Temperature Monitoring Devices
 o Table-top Temperature Monitoring Devices
 o Wearable Continuous Monitoring Devices
 o Invasive Temperature Monitoring Devices
 o Smart Temperature Monitoring Devices
• Hemodynamic/Pressure Monitoring Devices
 o Hemodynamic Monitors
 o Blood Pressure Monitors
 o Disposables
• Fetal & Neonatal Monitoring Devices
 o Fetal Monitoring Devices
 o Neonatal Monitoring Devices
• Neuromonitoring Devices
 o Electroencephalograph Machines
 o Electromyography Machines
 o Cerebral Oximeters
 o Intracranial Pressure Monitors
 o Magnetoencephalograph Machines
 o Transcranial Doppler Machines
• Weight Monitoring Devices
 o Digital
 o Analog
• Other Patient Monitoring Devices

By End User
• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Other End Users

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Patient Monitoring Devices Market Video Sample:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Patient Monitoring Devices Market By Product, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
    2.1. Research Data 
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation 
    2.3. Market Breakdown and Data Triangulation 
    2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Patient Monitoring Devices Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Type Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Patient Monitoring Devices Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Patient Monitoring Devices Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Type Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Type Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Patient Monitoring Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Blood Glucose Monitoring Systems
        7.1.1. Self-monitoring Blood Glucose Systems
        7.1.2. Continuous Glucose Monitoring Systems
   7.2. Cardiac Monitoring Devices
        7.2.1. ECG Devices
        7.2.2. Implantable Loop Recorders
        7.2.3. Event Monitors
        7.2.4. Mobile Cardiac Telemetry Monitors
        7.2.5. Smart/Wearable ECG Monitors
   7.3. Multi-parameter Monitoring Devices
        7.3.1. Low-acuity Monitoring Devices
        7.3.2. Mid-acuity Monitoring Devices
        7.3.3. High-acuity Monitoring Devices
   7.4. Respiratory Monitoring Devices
        7.4.1. Pulse Oximeters
        7.4.2. Spirometers
        7.4.3. Capnographs
        7.4.4. Peak Flow Meters
   7.5. Temperature Monitoring Devices
        7.5.1. Handheld Temperature Monitoring Devices
        7.5.2. Table-top Temperature Monitoring Devices
        7.5.3. Wearable Continuous Monitoring Devices
        7.5.4. Invasive Temperature Monitoring Devices
        7.5.5. Smart Temperature Monitoring Devices
   7.6. Hemodynamic/Pressure Monitoring Devices
        7.6.1. Hemodynamic Monitors
        7.6.2. Blood Pressure Monitors
        7.6.3. Disposables
   7.7. Fetal & Neonatal Monitoring Devices
        7.7.1. Fetal Monitoring Devices
        7.7.2. Neonatal Monitoring Devices
   7.8. Neuromonitoring Devices
        7.8.1. Electroencephalograph Machines
        7.8.2. Electromyography Machines
        7.8.3. Cerebral Oximeters
        7.8.4. Intracranial Pressure Monitors
        7.8.5. Magnetoencephalograph Machines
        7.8.6. Transcranial Doppler Machines
   7.9. Weight Monitoring Devices
        7.9.1. Digital
        7.9.2. Analog
   7.10. Other Patient Monitoring Devices

8. Patient Monitoring Devices Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Hospitals
   8.2. Ambulatory Surgery Centers
   8.3. Home Care Settings
   8.4. Other End Users

9. North America Patient Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   9.1. Introduction
   9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        9.2.1. U.S.A
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Market Size (USD Million) Forecast for North America 2022-2028

10. Latin America Patient Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. Brazil
          10.2.2. Venezuela
          10.2.3. Argentina
          10.2.4. Rest of Latin America
    10.3. Market Size (USD Million) Forecast for Latin America 2022-2028

11. Europe Patient Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Germany
          11.2.2. U.K         
          11.2.3. France
          11.2.4. Italy
          11.2.5. Spain
          11.2.6. Russia
          11.2.7. Poland
          11.2.8. Rest of Europe
    11.3. Market Size (USD Million) Forecast for Europe 2022-2028

12. Asia Pacific Patient Monitoring Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Japan
          12.2.2. China
          12.2.3. India
          12.2.4. Australia and New Zealand
          12.2.5. ASEAN
          12.2.6. Rest of Asia Pacific
    12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

13. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. GCC
          13.2.2. Israel
          13.2.3. South Africa
          13.2.4. Rest of MEA
    13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Market Share Analysis and Competitive Landscape   
    14.1. Global Landscape - Key Players, Revenue and Presence
    14.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    14.3. Global Emerging Companies
    14.4. North America - Market Share Analysis and Key Regional Players
    14.5. Europe - Market Share Analysis and Key Regional Players
    14.6. Asia Pacific - Market Share Analysis and Key Regional Players
    14.7. Global Key Player - Growth Matrix

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    15.1. Solvay Sa
          15.1.1. Company Overview
          15.1.2. Product Portfolio
          15.1.3. SWOT Analysis
          15.1.4. Financial Overview
          15.1.5. Strategic Overview
    15.2. SABIC
          15.2.1. Company Overview
          15.2.2. Product Portfolio
          15.2.3. SWOT Analysis
          15.2.4. Financial Overview
          15.2.5. Strategic Overview                         
    15.3. Mitsubishi Chemical Corporation
          15.3.1. Company Overview
          15.3.2. Product Portfolio
          15.3.3. SWOT Analysis
          15.3.4. Financial Overview
          15.3.5. Strategic Overview
    15.4. Evonik Industries AG
          15.4.1. Company Overview
          15.4.2. Product Portfolio
          15.4.3. SWOT Analysis
          15.4.4. Financial Overview
          15.4.5. Strategic Overview
    15.5. Arkema SA
          15.5.1. Company Overview
          15.5.2. Product Portfolio
          15.5.3. SWOT Analysis
          15.5.4. Financial Overview
          15.5.5. Strategic Overview          
    15.6. Ensinger
          15.6.1. Company Overview
          15.6.2. Product Portfolio
          15.6.3. SWOT Analysis
          15.6.4. Financial Overview
          15.6.5. Strategic Overview      
    15.7. Victrex PLC
          15.7.1. Company Overview
          15.7.2. Product Portfolio
          15.7.3. SWOT Analysis
          15.7.4. Financial Overview
          15.7.5. Strategic Overview
    15.8. Rochling SE & Co. AG
          15.8.1. Company Overview
          15.8.2. Product Portfolio
          15.8.3. SWOT Analysis
          15.8.4. Financial Overview
          15.8.5. Strategic Overview 
    15.9. Raumedic AG
          15.9.1. Company Overview
          15.9.2. Product Portfolio
          15.9.3. SWOT Analysis
          15.9.4. Financial Overview
          15.9.5. Strategic Overview 
    15.10.The Chemours Company         
          15.10.1. Company Overview
          15.10.2. Product Portfolio
          15.10.3. SWOT Analysis
          15.10.4. Financial Overview
          15.10.5. Strategic Overview 
    15.11.Saint-Gobain Performance Plastic
          15.11.1. Company Overview
          15.11.2. Product Portfolio
          15.11.3. SWOT Analysis
          15.11.4. Financial Overview
          15.11.5. Strategic Overview 
    15.12.Celanese Corporation
          15.12.1. Company Overview
          15.12.2. Product Portfolio
          15.12.3. SWOT Analysis
          15.12.4. Financial Overview
          15.12.5. Strategic Overview 
    15.13.Trelleborg
          15.13.1. Company Overview
          15.13.2. Product Portfolio
          15.13.3. SWOT Analysis
          15.13.4. Financial Overview
          15.13.5. Strategic Overview 
    15.14.Tekni-Plex
          15.14.1. Company Overview
          15.14.2. Product Portfolio
          15.14.3. SWOT Analysis
          15.14.4. Financial Overview
          15.14.5. Strategic Overview 
     15.15.Biomerics
          15.15.1. Company Overview
          15.15.2. Product Portfolio
          15.15.3. SWOT Analysis
          15.15.4. Financial Overview
          15.15.5. Strategic Overview 

16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations

17. FutureWise SME Key Takeaway Points for Client

Tables

Figures